As the COVID-19 pandemic enters a third year, thousands of patients who were considered recovered are experiencing residual respiratory and cardiac symptoms. Mount Sinai is taking on this challenge through a nationwide health consortium study funded by the National Institutes of Health (NIH) that will explore the long-term impacts of SARS-CoV-2, the virus that causes COVID-19.
The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative will assess the post-acute sequelae of SARS-CoV-2 infection (PASC). Mount Sinai, which participated in the design of the initiative, will serve as a hub site for two cohort studies as part of it: one involving an autopsy cohort and the other focused on an adult cohort. Alexander Charney, MD, PhD, the lead Principal Investigator at Mount Sinai, says respiratory concerns will be a major focus of this undertaking.
Referring a patient is easy. Just click the “Refer a Patient Online” button